# Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis

> **NCT00209287** · PHASE4 · TERMINATED · sponsor: **Ferring Pharmaceuticals** · enrollment: 6 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **BEHAVIORAL:** Observe patients with inactive ulcerative colitis

## Key facts

- **NCT ID:** NCT00209287
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-06
- **Primary completion:** 2006-12
- **Final completion:** 2007-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Recruitment problematic
- **Last updated:** 2012-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209287, "Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00209287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*